UBC Medical Indonesia Tbk. vs Sawit Sumbermas Sarana Tbk — how do they compare? UBC Medical Indonesia Tbk. trades at Rp148 (market cap 576.7B, 3.48M 24h volume), while Sawit Sumbermas Sarana Tbk trades at Rp945 (market cap 8.38T, 12.26M 24h volume). The key difference: Sawit Sumbermas Sarana Tbk is far larger — about 14.5× UBC Medical Indonesia Tbk.'s market cap, and Sawit Sumbermas Sarana Tbk is more actively traded (12.26M versus 3.48M). Which is the better fit depends on your goals.
| LABS | SSMS | |
|---|---|---|
Market Cap | 576.7B | 8.38T |
Volume | 3.48M | 12.26M |
Lot | 34.82K | 122.55K |
Turnover | 522.79M | 11.26B |
Average Price | 150.13 | 918.63 |
Value | 522.79M | 11.26B |
Indicative Equilibrium Price | 148 | 945 |
Indicative Equilibrium Volume | 350 | 1.05K |
Trailing returns across standard periods
Latest headlines on both assets
PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →PT Sawit Sumbermas Sarana Tbk (the Company) was established in Jakarta based on the Notarial Deed No. 51 of Enimarya Agoes Suwarko, S.H., dated November 22, 1995.
Read more on SSMS →